These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9012804)

  • 21. Influence of the P5 residue on alpha1-proteinase inhibitor mechanism.
    Chaillan-Huntington CE; Patston PA
    J Biol Chem; 1998 Feb; 273(8):4569-73. PubMed ID: 9468513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase.
    Dementiev A; Dobó J; Gettins PG
    J Biol Chem; 2006 Feb; 281(6):3452-7. PubMed ID: 16321984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The native metastable fold of C1-inhibitor is stabilized by disulfide bonds.
    Simonovic I; Patston PA
    Biochim Biophys Acta; 2000 Aug; 1481(1):97-102. PubMed ID: 11004579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of a serpin-protease complex shows inhibition by deformation.
    Huntington JA; Read RJ; Carrell RW
    Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a human alpha1-antitrypsin variant that is as stable as ovalbumin.
    Lee KN; Im H; Kang SW; Yu MH
    J Biol Chem; 1998 Jan; 273(5):2509-16. PubMed ID: 9446551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions.
    Matheson NR; van Halbeek H; Travis J
    J Biol Chem; 1991 Jul; 266(21):13489-91. PubMed ID: 1856187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structure of a serpin-protease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites.
    Fa M; Bergström F; Hägglöf P; Wilczynska M; Johansson LB; Ny T
    Structure; 2000 Apr; 8(4):397-405. PubMed ID: 10801484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining serpin conformational distributions with single molecule fluorescence.
    Mushero N; Gershenson A
    Methods Enzymol; 2011; 501():351-77. PubMed ID: 22078542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of NMR to study serpin function.
    Gettins PG; Backovic M; Peterson FC
    Methods; 2004 Feb; 32(2):120-9. PubMed ID: 14698624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
    Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
    Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular contortionism - on the physical limits of serpin 'loop-sheet' polymers.
    Huntington JA; Whisstock JC
    Biol Chem; 2010 Aug; 391(8):973-82. PubMed ID: 20731544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into beta-sheet A.
    Lawrence DA; Olson ST; Muhammad S; Day DE; Kvassman JO; Ginsburg D; Shore JD
    J Biol Chem; 2000 Feb; 275(8):5839-44. PubMed ID: 10681574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folding mechanism of the metastable serpin α1-antitrypsin.
    Tsutsui Y; Dela Cruz R; Wintrode PL
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4467-72. PubMed ID: 22392975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides.
    Chowdhury P; Wang W; Lavender S; Bunagan MR; Klemke JW; Tang J; Saven JG; Cooperman BS; Gai F
    J Mol Biol; 2007 Jun; 369(2):462-73. PubMed ID: 17442346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic dissection of alpha 1-antitrypsin inhibition mechanism.
    Shin JS; Yu MH
    J Biol Chem; 2002 Apr; 277(14):11629-35. PubMed ID: 11786547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
    Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
    Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structure of a Michaelis serpin-protease complex.
    Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
    Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways.
    Hood DB; Huntington JA; Gettins PG
    Biochemistry; 1994 Jul; 33(28):8538-47. PubMed ID: 8031789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.